Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.
This year's conference provided newer insights on the complications of antiretroviral therapy, as well as into the complications that arise from HIV infection itself. Many presentations at the conference centered around metabolic complications of therapy, including lipid abnormalities, diabetes, body composition changes, bone disorders, and cardiovascular disease. New data on complications of HIV infection itself were presented, including those on coinfections with hepatitis B, C, and herpes simplex viruses, malaria, and tuberculosis, as well as complications that are important during pregnancy. This article summarizes these presentations.
Currier
Judith S
JS
University of California Los Angeles, Los Angeles, CA, USA.
Havlir
Diane V
DV
D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D015897:Comorbidity; D048909:Diabetes Complications; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006561:Herpes Simplex / Q000150:complications; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced; D008288:Malaria / Q000150:complications; D010024:Osteoporosis / Q000139:chemically induced; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D014397:Tuberculosis, Pulmonary / Q000150:complications
D044966:Anti-Retroviral Agents